Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Dec 18;189(50):E1541-E1542.
doi: 10.1503/cmaj.171070.

We need to mandate drug cost transparency on electronic medical records

Iris Gorfinkel  1 , Joel Lexchin  2
Affiliations

We need to mandate drug cost transparency on electronic medical records

Iris Gorfinkel et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Competing interests: Iris Gorfinkel has received research grants from Astellas, Mundipharma, GSK, Serenity, Ferring and Romark, and has served on an advisory board for GSK. Joel Lexchin has received consultant fees from the US Agency for Healthcare Research and Quality for a project researching indication-based prescribing; and from the Government of Canada, the Ontario Supporting Patient-Oriented Research Support Unit and St. Michael’s Hospital Foundation for a project determining which drugs should be distributed free of charge by family physicians. He also received renumeration from The Canadian Institute for being on a panel that discussed a pharmacare plan for Canada. He is a member of the Foundation Board of Health Action International. No other competing interests were declared.

References

    1. Prescription medication use by Canadians aged 6 to 79. Ottawa: Statistics Canada; 2015. Available: www.statcan.gc.ca/pub/82-003-x/2014006/article/14032-eng.htm (accessed 2017 Nov. 1).
    1. Reichert S, Simon T, Ham EA. Physicians’ attitudes about prescribing and knowledge of the costs of common medications. Arch Intern Med 2000;160:2799–803. - PubMed
    1. Cassels A, Lexchin J. Potential savings from therapeutic substitution of 10 of Canada’s most dispensed prescription drugs. In: Temple N, Thompson A, editors. Excessive medical spending: facing the challange. Oxford (UK): Radcliffe Publishing; 2007:80–92.
    1. Morgan SG, Bassett KL, Wright JM, et al. “Breakthrough” drugs and growth in expenditure on prescription drugs in Canada. BMJ 2005;331:815–6. - PMC - PubMed
    1. Milan R, Vasiliadis HM, Gontijo Guerra S, et al. Out-of-pocket costs and adherence to antihypertensive agents among older adults covered by the public drug insurance plan in Quebec. Patient Prefer Adherence 2017;11:1513–22. - PMC - PubMed